Screening for breast cancer

U.S. preventive services task force recommendation statement

Ned Calonge, Diana B. Petitti, Thomas G. DeWitt, Allen J. Dietrich, Kimberly D. Gregory, David Grossman, George Isham, Michael L. LeFevre, Rosanne M. Leipzig, Lucy Nelle Marion, Bernadette Melnyk, Virginia A. Moyer, Judith K. Ockene, George F. Sawaya, J. Sanford Schwartz, Timothy Wilt

Research output: Contribution to journalReview article

1272 Citations (Scopus)

Abstract

Description: Update of the 2002 U.S. Preventive Services Task Force (USPSTF) recommendation statement on screening for breast cancer in the general population. Methods: The USPSTF examined the evidence on the efficacy of 5 screening modalities in reducing mortality from breast cancer: film mammography, clinical breast examination, breast self-examination, digital mammography, and magnetic resonance imaging in order to update the 2002 recommendation. To accomplish this update, the USPSTF commissioned 2 studies: 1) a targeted systematic evidence review of 6 selected questions relating to benefits and harms of screening, and 2) a decision analysis that used population modeling techniques to compare the expected health outcomes and resource requirements of starting and ending mammography screening at different ages and using annual versus biennial screening intervals. Recommendations: The USPSTF recommends against routine screening mammography in women aged 40 to 49 years. The decision to start regular, biennial screening mammography before the age of 50 years should be an individual one and take into account patient context, including the patient's values regarding specific benefits and harms. (Grade C recommendation) The USPSTF recommends biennial screening mammography for women between the ages of 50 and 74 years. (Grade B recommendation) The USPSTF concludes that the current evidence is insufficient to assess the additional benefits and harms of screening mammography in women 75 years or older. (I statement) The USPSTF concludes that the current evidence is insufficient to assess the additional benefits and harms of clinical breast examination beyond screening mammography in women 40 years or older. (I statement) The USPSTF recommends against clinicians teaching women how to perform breast self-examination. (Grade D recommendation) The USPSTF concludes that the current evidence is insufficient to assess additional benefits and harms of either digital mammography or magnetic resonance imaging instead of film mammography as screening modalities for breast cancer. (I statement).

Original languageEnglish (US)
Pages (from-to)716-726
Number of pages11
JournalAnnals of internal medicine
Volume151
Issue number10
DOIs
StatePublished - Nov 17 2009

Fingerprint

Advisory Committees
Mammography
Breast Neoplasms
Breast Self-Examination
Breast
Magnetic Resonance Imaging
Decision Support Techniques
Health Resources
Population
Teaching
Mortality

ASJC Scopus subject areas

  • Internal Medicine

Cite this

Calonge, N., Petitti, D. B., DeWitt, T. G., Dietrich, A. J., Gregory, K. D., Grossman, D., ... Wilt, T. (2009). Screening for breast cancer: U.S. preventive services task force recommendation statement. Annals of internal medicine, 151(10), 716-726. https://doi.org/10.1059/0003-4819-151-10-200911170-00008

Screening for breast cancer : U.S. preventive services task force recommendation statement. / Calonge, Ned; Petitti, Diana B.; DeWitt, Thomas G.; Dietrich, Allen J.; Gregory, Kimberly D.; Grossman, David; Isham, George; LeFevre, Michael L.; Leipzig, Rosanne M.; Marion, Lucy Nelle; Melnyk, Bernadette; Moyer, Virginia A.; Ockene, Judith K.; Sawaya, George F.; Schwartz, J. Sanford; Wilt, Timothy.

In: Annals of internal medicine, Vol. 151, No. 10, 17.11.2009, p. 716-726.

Research output: Contribution to journalReview article

Calonge, N, Petitti, DB, DeWitt, TG, Dietrich, AJ, Gregory, KD, Grossman, D, Isham, G, LeFevre, ML, Leipzig, RM, Marion, LN, Melnyk, B, Moyer, VA, Ockene, JK, Sawaya, GF, Schwartz, JS & Wilt, T 2009, 'Screening for breast cancer: U.S. preventive services task force recommendation statement', Annals of internal medicine, vol. 151, no. 10, pp. 716-726. https://doi.org/10.1059/0003-4819-151-10-200911170-00008
Calonge, Ned ; Petitti, Diana B. ; DeWitt, Thomas G. ; Dietrich, Allen J. ; Gregory, Kimberly D. ; Grossman, David ; Isham, George ; LeFevre, Michael L. ; Leipzig, Rosanne M. ; Marion, Lucy Nelle ; Melnyk, Bernadette ; Moyer, Virginia A. ; Ockene, Judith K. ; Sawaya, George F. ; Schwartz, J. Sanford ; Wilt, Timothy. / Screening for breast cancer : U.S. preventive services task force recommendation statement. In: Annals of internal medicine. 2009 ; Vol. 151, No. 10. pp. 716-726.
@article{ea84d122ab654637b722f0959ea3fa88,
title = "Screening for breast cancer: U.S. preventive services task force recommendation statement",
abstract = "Description: Update of the 2002 U.S. Preventive Services Task Force (USPSTF) recommendation statement on screening for breast cancer in the general population. Methods: The USPSTF examined the evidence on the efficacy of 5 screening modalities in reducing mortality from breast cancer: film mammography, clinical breast examination, breast self-examination, digital mammography, and magnetic resonance imaging in order to update the 2002 recommendation. To accomplish this update, the USPSTF commissioned 2 studies: 1) a targeted systematic evidence review of 6 selected questions relating to benefits and harms of screening, and 2) a decision analysis that used population modeling techniques to compare the expected health outcomes and resource requirements of starting and ending mammography screening at different ages and using annual versus biennial screening intervals. Recommendations: The USPSTF recommends against routine screening mammography in women aged 40 to 49 years. The decision to start regular, biennial screening mammography before the age of 50 years should be an individual one and take into account patient context, including the patient's values regarding specific benefits and harms. (Grade C recommendation) The USPSTF recommends biennial screening mammography for women between the ages of 50 and 74 years. (Grade B recommendation) The USPSTF concludes that the current evidence is insufficient to assess the additional benefits and harms of screening mammography in women 75 years or older. (I statement) The USPSTF concludes that the current evidence is insufficient to assess the additional benefits and harms of clinical breast examination beyond screening mammography in women 40 years or older. (I statement) The USPSTF recommends against clinicians teaching women how to perform breast self-examination. (Grade D recommendation) The USPSTF concludes that the current evidence is insufficient to assess additional benefits and harms of either digital mammography or magnetic resonance imaging instead of film mammography as screening modalities for breast cancer. (I statement).",
author = "Ned Calonge and Petitti, {Diana B.} and DeWitt, {Thomas G.} and Dietrich, {Allen J.} and Gregory, {Kimberly D.} and David Grossman and George Isham and LeFevre, {Michael L.} and Leipzig, {Rosanne M.} and Marion, {Lucy Nelle} and Bernadette Melnyk and Moyer, {Virginia A.} and Ockene, {Judith K.} and Sawaya, {George F.} and Schwartz, {J. Sanford} and Timothy Wilt",
year = "2009",
month = "11",
day = "17",
doi = "10.1059/0003-4819-151-10-200911170-00008",
language = "English (US)",
volume = "151",
pages = "716--726",
journal = "Annals of Internal Medicine",
issn = "0003-4819",
publisher = "American College of Physicians",
number = "10",

}

TY - JOUR

T1 - Screening for breast cancer

T2 - U.S. preventive services task force recommendation statement

AU - Calonge, Ned

AU - Petitti, Diana B.

AU - DeWitt, Thomas G.

AU - Dietrich, Allen J.

AU - Gregory, Kimberly D.

AU - Grossman, David

AU - Isham, George

AU - LeFevre, Michael L.

AU - Leipzig, Rosanne M.

AU - Marion, Lucy Nelle

AU - Melnyk, Bernadette

AU - Moyer, Virginia A.

AU - Ockene, Judith K.

AU - Sawaya, George F.

AU - Schwartz, J. Sanford

AU - Wilt, Timothy

PY - 2009/11/17

Y1 - 2009/11/17

N2 - Description: Update of the 2002 U.S. Preventive Services Task Force (USPSTF) recommendation statement on screening for breast cancer in the general population. Methods: The USPSTF examined the evidence on the efficacy of 5 screening modalities in reducing mortality from breast cancer: film mammography, clinical breast examination, breast self-examination, digital mammography, and magnetic resonance imaging in order to update the 2002 recommendation. To accomplish this update, the USPSTF commissioned 2 studies: 1) a targeted systematic evidence review of 6 selected questions relating to benefits and harms of screening, and 2) a decision analysis that used population modeling techniques to compare the expected health outcomes and resource requirements of starting and ending mammography screening at different ages and using annual versus biennial screening intervals. Recommendations: The USPSTF recommends against routine screening mammography in women aged 40 to 49 years. The decision to start regular, biennial screening mammography before the age of 50 years should be an individual one and take into account patient context, including the patient's values regarding specific benefits and harms. (Grade C recommendation) The USPSTF recommends biennial screening mammography for women between the ages of 50 and 74 years. (Grade B recommendation) The USPSTF concludes that the current evidence is insufficient to assess the additional benefits and harms of screening mammography in women 75 years or older. (I statement) The USPSTF concludes that the current evidence is insufficient to assess the additional benefits and harms of clinical breast examination beyond screening mammography in women 40 years or older. (I statement) The USPSTF recommends against clinicians teaching women how to perform breast self-examination. (Grade D recommendation) The USPSTF concludes that the current evidence is insufficient to assess additional benefits and harms of either digital mammography or magnetic resonance imaging instead of film mammography as screening modalities for breast cancer. (I statement).

AB - Description: Update of the 2002 U.S. Preventive Services Task Force (USPSTF) recommendation statement on screening for breast cancer in the general population. Methods: The USPSTF examined the evidence on the efficacy of 5 screening modalities in reducing mortality from breast cancer: film mammography, clinical breast examination, breast self-examination, digital mammography, and magnetic resonance imaging in order to update the 2002 recommendation. To accomplish this update, the USPSTF commissioned 2 studies: 1) a targeted systematic evidence review of 6 selected questions relating to benefits and harms of screening, and 2) a decision analysis that used population modeling techniques to compare the expected health outcomes and resource requirements of starting and ending mammography screening at different ages and using annual versus biennial screening intervals. Recommendations: The USPSTF recommends against routine screening mammography in women aged 40 to 49 years. The decision to start regular, biennial screening mammography before the age of 50 years should be an individual one and take into account patient context, including the patient's values regarding specific benefits and harms. (Grade C recommendation) The USPSTF recommends biennial screening mammography for women between the ages of 50 and 74 years. (Grade B recommendation) The USPSTF concludes that the current evidence is insufficient to assess the additional benefits and harms of screening mammography in women 75 years or older. (I statement) The USPSTF concludes that the current evidence is insufficient to assess the additional benefits and harms of clinical breast examination beyond screening mammography in women 40 years or older. (I statement) The USPSTF recommends against clinicians teaching women how to perform breast self-examination. (Grade D recommendation) The USPSTF concludes that the current evidence is insufficient to assess additional benefits and harms of either digital mammography or magnetic resonance imaging instead of film mammography as screening modalities for breast cancer. (I statement).

UR - http://www.scopus.com/inward/record.url?scp=72049100691&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=72049100691&partnerID=8YFLogxK

U2 - 10.1059/0003-4819-151-10-200911170-00008

DO - 10.1059/0003-4819-151-10-200911170-00008

M3 - Review article

VL - 151

SP - 716

EP - 726

JO - Annals of Internal Medicine

JF - Annals of Internal Medicine

SN - 0003-4819

IS - 10

ER -